The ALS Ltd share price jumps on hopes of strong profit results in May

The ALS Ltd (ASX: ALQ) share price jumped higher today after Macquarie Group Ltd (ASX: MQG) stoked optimism that it will deliver a profit at the top end of management guidance.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The ALS Ltd (ASX: ALQ) share price jumped higher today after Macquarie Group Ltd (ASX: MQG) stoked optimism that the laboratory testing company will deliver a profit at the top end of management guidance in two months.

The ALQ share price jumped 1.8% to $7.80 while the S&P/ASX 200 (Index:^AXJO) (ASX:XJO) index closed 0.6% higher on Thursday.

Despite its outperformance today, ALS needs to do lots of catching up as its shares are still down close to 13% over the past 6 months compared to a flat performance by the top 200 benchmark.

Earnings set to grow

But playing catch-up is what Macquarie expects ALS to do and the opportunity could come when management hands in its full year profit result on 21 May with its Life Sciences division showing good growth and hitting its margin target.

"LS [Life Sciences] saw strong sequential improvement in 1H and we expect solid 130bp 2H margin expansion on pcp [previous corresponding period]," said Macquarie.

"This equates to 60bp forecast lift in FY19 EBIT margins to 14.5% which is expected to be driven Al Control [acquisition] delivering to plan and restructuring benefits [and] improving end market demand in Canada, LatAm and Australia."

The US government shutdown earlier this year could hurt its bottom line (the US government is a customer), but that's probably not enough to dampen its results.

It's Minerals division (it tests ores from exploratory drilling) is also expected to deliver good growth but will probably slow compared to the first half of FY19.

Macquarie has reiterated its "outperform" recommendation on the stock with a price target of $8.76 a share as the broker is forecasting ALS to post a full year net profit of $175 million compared to management's guidance of $170 million to $175 million.

Foolish takeaway

But that's not the only reason to like the stock. ALS provides good international exposure and is leveraged to buoyant mining activity.

The stock is also trading on a FY20 consensus price-earnings (P/E) multiple of 18.8 times, which I think is good value given its growth profile.

But this isn't the only stock exposed to mining and infrastructure (two sectors that are well placed to grow). For that perspective, I also like construction engineering group Downer EDI Limited (ASX: DOW) and construction equipment company Seven Group Holdings Ltd (ASX: SVW).

Looking for blue-chips that are well placed to outperform this year? The experts at the Motley Fool have three more buy ideas for you. Follow the free link below to find out more.

Motley Fool contributor Brendon Lau owns shares of Seven Group Holdings Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Winning woman smiles and holds big cup while losing woman looks unhappy with small cup
Share Gainers

Here are the top 10 ASX 200 shares today

It was a dour Tuesday for ASX investors.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why Brightstar Resources, Immutep, Pilbara Minerals, and Race Oncology shares are roaring higher

These shares are having a strong session on Tuesday. But why?

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Healthcare Shares

Guess which ASX 300 healthcare share is rocketing 28% on global expansion news

Investors are piling into the ASX 300 healthcare share on Tuesday. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a Garfield kind of Monday for investors.

Read more »

Happy shareholders clap and smile as they listen to a company earnings report.
Share Gainers

Why Artrya, Clinuvel, Imugene, and Pilbara Minerals shares are storming higher today

These shares are starting the week in a positive fashion. But why?

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Share Gainers

4 ASX 200 stocks smashing the benchmark this week

Investors have been piling into these four ASX 200 stocks this week. Let’s see why.

Read more »